Circ-Hipk3 in Adipose Derived Stem Cells Exosome Alleviates Myocardial Infarction Induced Myocardial Damage by

Guoxun Yang1, Danpeng Nong2, Xiao Tang3

  • 1Institute of Hypertension Vascular Disease, Guangxi International Zhuang Medicine Hospital, No.8 Qiuyue Road, Wuxiang New District, Nanning, 530201, Guangxi, China. gnygxdt@163.com.

Biochemical Genetics
|July 22, 2025
PubMed

Insights

Adipose tissue-derived mesenchymal stem cell exosomes (ADSC-Exos) show therapeutic potential for myocardial infarction (MI). ADSC-Exos containing circ-Hipk3 protect against cardiac injury by modulating the miR-138-5p/Sirt1 pathway and autophagy.

Area of Science:

  • Cardiovascular Biology
  • Regenerative Medicine
  • Molecular Biology

Background:

  • Myocardial infarction (MI) is a leading cause of death globally.
  • Stem cell-derived exosomes show promise in repairing MI-induced heart damage.
  • The cardioprotective role of adipose tissue-derived mesenchymal stem cell exosomes (ADSC-Exos) requires further elucidation.

Purpose of the Study:

  • To investigate the protective effects of ADSC-Exos on myocardial injury in a mouse model of MI.
  • To explore the underlying molecular mechanisms, focusing on the role of circ-Hipk3, miR-138-5p, and Sirt1.

Main Methods:

  • Establishment of a myocardial infarction (MI) model in C57BL/6J mice.
  • Investigation of cellular and molecular mechanisms using cultured ADSCs and HMEC-1 cells.
  • Analysis of inflammatory factors via ELISA and molecular interactions using luciferase reporter assays.

Main Results:

  • ADSC-Exos treatment significantly alleviated MI-induced myocardial damage by promoting autophagy and inhibiting inflammation.
  • Circ-Hipk3 plays a crucial role in the protective effects of ADSC-Exos.
  • The miR-138-5p/Sirt1 axis was identified downstream of circ-Hipk3, mediating autophagy and inflammatory responses.

Conclusions:

  • ADSC-Exos protect against cardiac injury in MI through the circ-Hipk3/miR-138-5p/Sirt1 axis, modulating autophagy signaling.
  • Circ-Hipk3 within ADSC-Exos demonstrates significant therapeutic potential for treating MI-induced cardiac injury.